Dr. Thio has two primary research interests. The first is HIV-HBV co-infection, where she has projects in Nigeria, Australia and the United States. In addition, she is leading a multicenter international study looking at HIV-HBV co-infection within the ACTG framework.
Her second area is on the human genetic determinants of HBV and HCV clearance, where she examines polymorphisms in human genes in persons that have either recovered from or have a persistent viral hepatitis infection.
Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. "Global elimination of mother-to-child transmission of hepatitis B: Revisiting the current strategy." The Lancet Infectious Diseases. 2015;15(8):981-985.
Ehrhardt S, Xie C, Guo N, Nelson KE, Thio CL. "Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: A review of the evidence." Clinical Infectious Diseases. 2015;60(2):275-278.
Vergara C, Thio CL, Thomas D, Duggal P. "Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population." Hepatology. 2015 Jun 23. doi: 10.1002/hep.27954. [Epub ahead of print].
Geller G, Dvoskin R, Thio CL, Duggal P, Lewis MH, Bailey TC, Sutherland A, Salmon DA, Kahn JP. "Genomics and infectious disease: A call to identify the ethical, legal and social implications for public health and clinical practice." Genome Med. 2014 Nov 18;6(11):106. doi: 10.1186/s13073-014-0106-2. eCollection 2014.
Chun HM, Mesner O, Thio CT, Bebu I, Macalino G, Agan BK, Bradley WP, Malia J, Peel SA, Jagodzinski LL, et al.
"HIV outcomes in hepatitis B virus coinfected individuals on HAART." Journal of Acquired Immune Deficiency Syndromes. 2014;66(2):197-205.